Immunome Inc. financial data

Symbol
IMNM on Nasdaq
Location
18702 N. Creek Parkway, Suite 100, Bothell, WA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 790 % +5.78%
Debt-to-equity 15.4 % -8.67%
Return On Equity -87.2 % +37.6%
Return On Assets -75.6 % +36.8%
Operating Margin -2.42K % +22.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 91.7M shares +46.9%
Common Stock, Shares, Outstanding 91.7M shares +51.8%
Entity Public Float 643M USD +751%
Common Stock, Value, Issued 9K USD +50%
Weighted Average Number of Shares Outstanding, Basic 88M shares +46.1%
Weighted Average Number of Shares Outstanding, Diluted 88M shares +46.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 9.68M USD -4.44%
Research and Development Expense 174M USD +91%
General and Administrative Expense 42.1M USD +37.9%
Operating Income (Loss) -234M USD +26.2%
Net Income (Loss) Attributable to Parent -223M USD +27.1%
Earnings Per Share, Basic -2 USD/shares +65.7%
Earnings Per Share, Diluted -2 USD/shares +65.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 273M USD +75.3%
Assets, Current 280M USD +14.7%
Property, Plant and Equipment, Net 11.6M USD +61.2%
Operating Lease, Right-of-Use Asset 3.13M USD +30.9%
Other Assets, Noncurrent 4.56M USD +42.4%
Assets 299M USD +16.5%
Accounts Payable, Current 6.15M USD +74.7%
Employee-related Liabilities, Current 7.17M USD +117%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 31.4M USD -20.4%
Contract with Customer, Liability, Noncurrent 2.21M USD -76.6%
Deferred Income Tax Liabilities, Net 1.03M USD +173%
Operating Lease, Liability, Noncurrent 4.01M USD +62.9%
Other Liabilities, Noncurrent 1.34M USD +2061%
Liabilities 35.5M USD -15.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD -100%
Retained Earnings (Accumulated Deficit) -658M USD -51.1%
Stockholders' Equity Attributable to Parent 264M USD +22.8%
Liabilities and Equity 299M USD +16.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -53.1M USD -375%
Net Cash Provided by (Used in) Financing Activities 162M USD -26.1%
Net Cash Provided by (Used in) Investing Activities 5.09M USD
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 91.7M shares +51.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 114M USD -33.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 273M USD +75.3%
Deferred Tax Assets, Valuation Allowance 107M USD +168%
Deferred Tax Assets, Gross 108M USD +168%
Operating Lease, Liability 4.01M USD +47.5%
Payments to Acquire Property, Plant, and Equipment 3.67M USD +69.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -223M USD +27%
Lessee, Operating Lease, Liability, to be Paid 17.2M USD +361%
Operating Lease, Liability, Current 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.33M USD +177%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.47M USD +66.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3.82M USD +504%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.38M USD
Deferred Tax Assets, Operating Loss Carryforwards 29.3M USD +28.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 56K USD +51.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.62M USD
Additional Paid in Capital 922M USD +41.8%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 611K USD +289%
Deferred Tax Assets, Net of Valuation Allowance 1.03M USD +173%
Share-based Payment Arrangement, Expense 23.3M USD +76.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%